Magnum Experiment 73

The chart shows the growth of an initial investment of $10,000 in Magnum Experiment 73, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Jan 12, 2024, Magnum Experiment 73's average daily return is +0.06%, while the average monthly return is +1.26%. At this rate, an investment would double in approximately 4.6 years.

Historically, 61% of months were positive and 39% were negative. The best month was May 2025 with a return of +6.5%, while the worst month was Mar 2025 at -5.2%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 3 months.

On a daily basis, Magnum Experiment 73 closed higher 58% of trading days. The best single day was Apr 9, 2025 with a return of +8.2%, while the worst single day was Apr 4, 2025 at -4.8%.

Magnum Experiment 73 has an annualized alpha of 0.28%, beta of 0.93, and R² of 0.97 versus S&P 500 Index. Calculated based on daily prices since January 12, 2024.

• This portfolio participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (91.17%) than losses (89.75%) — typical of diversified or defensive assets.
• With beta of 0.93 and R² of 0.97, this portfolio moves broadly in line with S&P 500 Index — much of its variation is explained by market exposure rather than independent behavior.

Magnum Experiment 73 has an expense ratio of 0.11%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

Magnum Experiment 73 ranks 39 for risk / return — below 39% of portfolios on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Magnum Experiment 73 Sharpe ratios as of Apr 11, 2026 (values are recalculated daily):

• 1-Year: 2.30
• All Time: 1.09

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 2.14 to 3.05, this portfolio's current Sharpe ratio falls between the 25th and 75th percentiles. This indicates that its risk-adjusted performance is in line with the majority of portfolios, suggesting a balanced approach to risk and return—likely suitable for a wide range of investors.

The chart below shows the rolling Sharpe ratio of Magnum Experiment 73 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Magnum Experiment 73 provided a 1.16% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Magnum Experiment 73. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Magnum Experiment 73 was 17.16%, occurring on Apr 8, 2025. Recovery took 52 trading sessions.

The current Magnum Experiment 73 drawdown is 2.36%.

The chart below shows the rolling one-month volatility.